Lumeva · MIG · United States · Headache specialist · captured by Luis Ortega on 24 Jan 2026 · reviewed by Dr. Elena Moretti on 26 Jan 2026
Marked as duplicate
Verbatim as captured; never edited
Headache specialist at Memorial Sloan Kettering raised real-world persistence during a congress meeting. They requested supporting literature and a follow-up discussion.
Human-approved by Dr. Elena Moretti on 26 Jan 2026
Real-world persistence: request for data reported by headache specialist (US).
helixor-private-llm-2026.05 · generated 24 Jan 2026, 10:00 UTC
AI summary
Real-world persistence raised by headache specialist; aligns with HEOR.
Source spans used by the model
Headache specialist at Memorial Sloan Kettering raised real-world persistence during a congress meeting. They requested supporting literature and a follow-up discussion.
| Field | AI suggestion | Final (human-approved) |
|---|---|---|
| Category | Health economics | Health economics |
| Function | HEOR | HEOR |
| Priority | Medium | Medium |
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 1 | 20% | 4.0 |
| Strategic alignment | 2 | 20% | 8.0 |
| Scientific importance | 5 | 15% | 15.0 |
| Urgency | 4 | 15% | 12.0 |
| Novelty | 2 | 10% | 4.0 |
| Actionability | 3 | 10% | 6.0 |
| Confidence | 5 | 5% | 5.0 |
| Breadth of occurrence | 4 | 5% | 4.0 |
| Total | Medium 58 | ||
No audit events in sample data
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
23 Jan 2026 · Dr. Benedikt Dubois, Memorial Sloan Kettering · MSL Luis Ortega
Insight
Reviewed 26 Jan 2026 by Dr. Elena Moretti
Action
Publication project · David Chen · In progress
Decision
Outcome
Closure
Duplicate of INS-0060 — Japanese regional PD-L1 turnaround of 10–14 days leads to chemotherapy initiation before results. Suggests Japanese testing-pathway guide and reflex-testing advocacy.